Cargando…

Survival analysis: coping with non proportional hazards in randomized trials

Detalles Bibliográficos
Autores principales:	Royston, Patrick, Parmar, Mahesh KB
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287711/ http://dx.doi.org/10.1186/1745-6215-12-S1-A136

Ejemplares similares

An approach to trial design and analysis in the era of non-proportional hazards of the treatment effect
por: Royston, Patrick, et al.
Publicado: (2014)

Analysis of survival data from trials with non-proportional hazards: an empirical comparison of methods
por: Royston, Patrick, et al.
Publicado: (2013)

Augmenting the logrank test in the design of clinical trials in which non-proportional hazards of the treatment effect may be anticipated
por: Royston, Patrick, et al.
Publicado: (2016)

Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome
por: Royston, Patrick, et al.
Publicado: (2013)

Equivalence and non inferiority trials
por: D’Agostino, Ralph B
Publicado: (2011)

INSP-04. Confirmatory adaptive designs for survival trials with several time-to-event endpoints
por: Schmidt, Rene
Publicado: (2022)

Statistical issues in the analysis of non-pharmacological therapy trials with clustering by care-provider or therapy group
por: Roberts, Chris
Publicado: (2011)

A new measure of predictive ability for survival models
por: Choodari-Oskooei, Babak, et al.
Publicado: (2011)

Emerging CNS involvement in FAP-TTR long survival patients
por: Maia, Luisa
Publicado: (2015)

Non invasive neurostimulation
por: Grazzi, Licia
Publicado: (2015)

EDI200 therapeutic trial
por: Huttner, Kenneth
Publicado: (2012)

The madness of HIV prevention trials
por: McCormack, S
Publicado: (2015)

Discussion session: biomarker trials
Publicado: (2015)

Investigator led trials: challenges and opportunities
por: Sandercock, Peter
Publicado: (2011)

Seven myths of randomisation in clinical trials
por: Senn, Stephen
Publicado: (2011)

Randomised controlled trials of complex interventions
por: Norrie, John
Publicado: (2011)

Removing unnecessary obstacles to randomised trials
por: Collins, Rory
Publicado: (2013)

Non headache phenotypes in pediatric age
por: Valeriani, Massimiliano
Publicado: (2015)

Strategies for handling missing data in randomised trials
por: White, Ian R
Publicado: (2011)

Identifying appropriate phase II trial designs
por: Brown, Sarah R
Publicado: (2011)

Trials in rare diseases: the need to think differently
por: Billingham, Lucinda, et al.
Publicado: (2011)

Using biomarkers prospectively in adaptive clinical trials
por: Berry, Donald A
Publicado: (2011)

Science in a crisis: conducting clinical trials in an emergency
por: Horby, P
Publicado: (2015)

Inflammatory control in AIDS-resistant non human primates
por: Jacquelin, Béatrice, et al.
Publicado: (2009)

The UK Medical Research Council and clinical trials, 1934-1960
por: Chalmers, Iain
Publicado: (2013)

Science, society and biosafety of a field trial with transgenic biofuel poplars
por: Van Acker, Rebecca, et al.
Publicado: (2011)

Developing sub-acute, non-acute and special groups in the universal grouper
por: Aljunid, Syed Mohamed
Publicado: (2012)

Developing sub-acute and non-acute Casemix classification: the Thailand experience
por: Pannarunothai, Supasit
Publicado: (2012)

Recruitment to trials - why is it hard and how might we make it less so?
por: Treweek, Shaun
Publicado: (2011)

When to decide to enroll a TTR-FAP patient in a Clinical Trial?
por: Buades, Juan
Publicado: (2015)

What does it take to be healthy? Investigating immune-deficiency in non-immunodeficient scenarios
por: Binda, Elisa, et al.
Publicado: (2012)

Streamlining regulation of clinical trials – update on the Academy of Medical Sciences review and government’s response
por: Ford, Gary A
Publicado: (2011)

Using economic modelling to contribute to the prioritisation and design and clinical trials: ready for prime time
por: Sculpher, Mark
Publicado: (2011)

INSP-01. What to do when you cannot randomize? Leveraging Historical Data in Efficient Study Designs for Pediatric Neuro-Oncology.
por: Onar-Thomas, Arzu
Publicado: (2022)

A multidisciplinary approach to the functional abnormalities of the migrainous brain and non-invasive interventions to treat them
por: Viganò, Alessandro, et al.
Publicado: (2013)

Bone ageing and HIV
por: Mallon, Patrick W
Publicado: (2010)

Bioinformatic analysis of allergens
por: Gendel, Steven
Publicado: (2011)

S5. Proffered paper: Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MGN1703: clinical and immunological predictive pretreatment factors of activity in the IMPACT trial
por: Schmoll, H, et al.
Publicado: (2014)

Comparative analysis of the vaginal microbiome in health and disease
por: White, Bryan A, et al.
Publicado: (2011)

Comparative genomic analysis of mouse and human mammary tumors
por: Perou, Charles M
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5am6nus4e5d01afn7sv60dnm95